Aristotle Capital Management 13F: Cuts CTVA Stake by $111M

Aristotle Capital Management decreased its holdings in Corteva, Inc. by 1.31 million shares.

Reviewed by automated data checks against the source filing. How we make and check alerts

Aristotle Capital Management sold 1,311,336 shares from its stake in Corteva, Inc. ($CTVA), a 6.51% decrease, according to a 13F filing with the SEC dated May 15, 2026. It reported 18,833,712 shares worth $1.60 billion at the end of the quarter.

Since the filing, $CTVA is down 3.3% after 1 week, down 7.7% after 1 month and up 4.9% to date (from the $12.28 close on May 15, 2026).

Find the original: Aristotle Capital Management 13F filings on SEC EDGAR

CTVA Corteva, Inc.
$12.88 +27.52% year to date
Daily close · Oct 16, 2026

Key Points

  • Aristotle Capital Management trimmed its Corteva, Inc. holdings by 1.31 million shares, reducing its position by 6.5% to 18.83 million shares.
  • Aristotle Capital Management held 18,833,712 $CTVA shares at quarter end, down 6.51% from the prior quarter.
  • Corteva, Inc. has a market cap of approximately $50.9 billion, with a P/E ratio of 41.16 and a 52-week range between $60.54 and $85.63.
  • Insider transactions included CEO Luther Kissam IV buying 24,138 shares, while analysts like Barclays maintained a 'buy' rating with a $91 target.

Get $CTVA trade alerts by text

We text you when insiders, Congress or big funds trade $CTVA. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Corteva, Inc. alert may contain errors. Disclosures

Aristotle Capital Management has reduced its stake in Corteva, Inc. (NYSE:CTVA) according to its latest 13F filing with the SEC. The firm trimmed its position by 1,311,336 shares, a 6.5% decrease, bringing its total holdings to 18,833,712 shares valued at approximately $1.41 billion as of the reporting period ending March 31, 2026.

What Changed in Aristotle Capital Management's Corteva, Inc. Position

Aristotle Capital Management's decision to reduce its holdings in Corteva, Inc. by over 1.31 million shares resulted in a total stake of 18,833,712 shares. This adjustment represents a 6.5% decrease from its previous holding of 20,145,048 shares. The investment is now worth about $1.41 billion.

Other Institutional Activity in Corteva, Inc.

Among other institutional investors, BlackRock, Inc. decreased its holdings in Corteva by 4,898,293 shares, leaving it with 54,710,452 shares valued at $4.58 billion. Vanguard Capital Management LLC significantly increased its position, adding 44,075,854 shares to hold a total of 44,075,854 shares worth nearly $3.69 billion. State Street Corp reduced its stake by 432,837 shares, ending with 36,138,039 shares valued at $3.03 billion. Meanwhile, Capital World Investors boosted its holdings by 14,642,858 shares, resulting in a total of 35,998,047 shares worth approximately $3.01 billion.

Corteva, Inc. Stock Up 557.5%

Shares of Corteva, Inc. (NYSE:CTVA) recently traded at $74.84. The company has a market capitalization of about $50.9 billion and a P/E ratio of 41.16. It sports a forward P/E of 18.56 and a beta of 0.572, indicating lower volatility compared to the market. The stock's 52-week low is $60.54, and its high is $85.63. Corteva has a 50-day moving average of $80.31 and a 200-day moving average of $72.71. Its current ratio is 1.467, with a quick ratio of 0.9 and a debt-to-equity ratio of 13.64.

Recent Earnings

Corteva, Inc. reported revenue of $17.89 billion, reflecting a growth rate of 11%. The company's earnings per share (EPS) is $1.85, with a net margin of 6.5% and a return on equity (ROE) of 5.1%. The next earnings report is scheduled for July 30, 2026.

Earnings drift grade

Outlook vs expectations on the last report — not price action.

B+ 82/100

Reported May 5, 2026

  1. Forward outlook

    3 analysts raised price targets.

  2. EPS & revenue

    EPS beat estimates by 25.4%. Revenue beat estimates by 3.6%.

  3. Profit surprise

    EBITDA beat by 13 percent. Operating income beat by 9 percent.

  4. Pre-earnings setup

    Expectations were about average.

  5. Analyst signal

    3 target raises.

  6. Earnings quality

    Gross margin up 1.5 points. Operating margin up 4.9 points. Positive free cash flow.

Earnings Call Summary

Corteva had a strong first quarter with organic sales up 7 percent, driven by seed volume growth of 6 percent and crop protection gains across all regions. Operating EBITDA jumped 21 percent year over year to over $1.4 billion, with margin expansion of 240 basis points coming from price gains, cost savings, and favorable currency effects. Management highlighted that net royalty expense fell another $30 million as the seed business moves toward royalty positive status later this year, particularly from licensing deals like Enlist soybeans in Brazil.

Guidance The company reaffirmed full-year operating EBITDA guidance of $4 billion to $4.2 billion with earnings per share of $3.45 to $3.70. Management expects continued volume growth in crop protection in Latin America in the second half, with seed pricing expected to improve in the back half despite near-term commodity cost headwinds. The company is incorporating a $40 million headwind from higher oil prices.

Good report. The company beat and showed some forward improvement, with a few meaningful caveats.

Dividend

Corteva, Inc. offers an annual dividend rate of $0.72 per share, yielding 0.95%. The company's dividend payout ratio stands at 38.38%.

Insider Buying and Selling at Corteva, Inc.

Recent insider activity at Corteva, Inc. included CEO Luther Kissam IV purchasing 24,138 shares on June 1, 2026. Other transactions on April 30, 2026, saw Janet Plaut Giesselman buying 96 shares, Nayaki Nayyar acquiring 401 shares, and Marcos Lutz selling 906 shares at an average price of $81.01. Klaus Engel also sold 906 shares on the same date.

Analysts Set New Price Targets

On June 11, 2026, Barclays maintained its 'buy' rating for Corteva, Inc. with a price target of $91. UBS, on June 9, 2026, upheld a 'hold' rating with an $86 target. Morgan Stanley reaffirmed its 'buy' rating on May 28, 2026, setting a target of $95. The consensus among 21 analysts is a 'buy' rating, with an average target price of $90.05.

About Corteva, Inc.

Corteva, Inc. is a leading player in the agricultural inputs industry, specializing in seeds and crop protection products. Headquartered in Indianapolis, Indiana, the company operates in various regions including the Americas, Asia Pacific, and EMEA. With approximately 21,500 employees, Corteva focuses on enhancing agricultural productivity through innovative solutions. Its CEO, Charles Victor Magro, oversees operations that aim to improve yield and crop health.

Bottom Line

Aristotle Capital Management's recent reduction of its position in Corteva, Inc. highlights ongoing adjustments in institutional portfolios. Investors keep a close eye on these filings to gauge institutional sentiment. It's important to remember that 13F filings are backward-looking and may not reflect current positions.

Source: Aristotle Capital Management's 13F filing on $CTVA (May 15, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Aristotle Capital Management 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts

Get $CTVA trade alerts by text